InsidersTradesSigma
Discover the full record of transactions filed by Ferguson Kenneth M., 董事. Director active across 1 company, notably Cyclacel Pharmaceuticals, Inc.. Aggregated, 2 filings have been recorded. History available since 14 June 2022. The latest transaction was disclosed on 14 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Kenneth M. Ferguson is a Director at Cyclacel Pharmaceuticals, Inc. As a board member, he contributes to the governance of the company and to strategic decision-making. Kenneth leverages his experience to guide the company's initiatives and ensure compliance with best governance practices.